NCT04084197View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

January 4, 2019

Conditions
Healthy
Interventions
DRUG

HIP1402

Tamsulosin (HanmiTams Capsule) 0.4mg

DRUG

HIP1801

Tamsulosin 0.4mg

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04084197 - A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects. | Biotech Hunter | Biotech Hunter